RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical setting.
Healer J, Thompson JK, Mackwell KL, Browne CD, Seager BA, Ngo A, Lowes KN, Silk SE, Pulido D, King LDW, Christen JM, Noe AR, Kotraiah V, Masendycz PJ, Rajagopalan R, Lucas L, Stanford MM, Soisson L, Diggs C, Miller R, Youll S, Wycherley K, Draper SJ, Cowman AF.
Healer J, et al. Among authors: wycherley k.
Front Cell Infect Microbiol. 2022 Dec 20;12:1049065. doi: 10.3389/fcimb.2022.1049065. eCollection 2022.
Front Cell Infect Microbiol. 2022.
PMID: 36605129
Free PMC article.